InvestorsHub Logo
Followers 77
Posts 30218
Boards Moderated 85
Alias Born 03/22/2005

Re: None

Thursday, 05/04/2023 12:23:59 PM

Thursday, May 04, 2023 12:23:59 PM

Post# of 447
>>> Quipt Home Medical Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Quipt Home Medical Corp.

May 2, 2023

CINCINNATI, May 02, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has received conditional approval from the Toronto Stock Exchange ("TSX") to graduate its listing from the TSX Venture Exchange (the "TSXV") to the TSX.

“Graduating to the Toronto Stock Exchange is a significant accomplishment, and I want to thank all our team members and shareholders for their ongoing support. Our ability to up-list demonstrates the evolution of our organization through the years and the ongoing momentum across the business in real time as we strive to become a national leader in respiratory care throughout the United States,” said Greg Crawford, Chairman and CEO of Quipt. “This up-listing is an important step towards improving liquidity and increasing our investor audience in North America and abroad. Given the continued financial and operational success, this up-listing, and our effort to inform investors of our robust growth, have us extremely optimistic about the future.”

Final approval of the listing is subject to the Company meeting certain customary conditions required by the TSX. The Company is working diligently to satisfy such listing conditions. Further details and a timeline for graduation will be announced in due course. Upon satisfaction of the TSX listing conditions, Quipt’s common shares will be delisted from the TSXV.

Shareholders are not required to exchange their share certificates or take any other action in connection with the TSX listing, as there will be no change in the trading symbol or CUSIP for the common shares. The Company will continue to trade its common shares on the NASDAQ in the United States under the symbol "QIPT".


The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services, and making life easier for the patient.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.